RollaF.Abu-ArjaMD

Pediatric Hematology & Oncology • Columbus, OH

Associate Professor, Pediatrics, Nationwide Children's Hospital/Ohio State University

Join to view full profile

Dr. Abu-Arja is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abu-Arja's full profile

Already have an account?

Office
700 Childrens Dr
Columbus, OH 43205
Phone+1 614-722-3552

Fax+1 614-722-3699

Education & Training

University of Iowa Hospitals and ClinicsFellowship, Pediatric Hematology/Oncology, 2004 - 2008
University of Iowa Hospitals and ClinicsResidency, Pediatrics, 2001 - 2004
University of Jordan Faculty of MedicineClass of 1998

Certifications & Licensure

OH State Medical License 2011 - 2025
IA State Medical License 2004 - 2015
NJ State Medical License 2002 - 2006
VA State Medical License 2005 - 2006
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Natural History Study of SCID Disorders Start of enrollment: 2010 Sep 02
Enrolling by invitation
Double Cord Versus Haploidentical (BMT CTN 1101) Start of enrollment: 2012 Jun 01
Completed
Phase 3
Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990 Start of enrollment: 2014 Feb 02
Completed
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995 Start of enrollment: 2014 Jun 01
Enrolling by invitation
Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies
No longer available
Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia Start of enrollment: 2018 Mar 02
Active, not recruiting
Phase 1, Phase 2
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Roles: Principal Investigator, Contact
αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT) Start of enrollment: 2023 Dec 18
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency-Centromeric Instability-Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Pa...
Dagmar Berghuis, Lubna S Mehyar, Rolla Abu-Arja, Michael H Albert, Jessie L Barnum
Journal of Clinical Immunology. 2024-08-21
4 citations
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol.
Sarah Nikiforow, Jennifer S Whangbo, Ran Reshef, Donald E Tsai, Nancy Bunin
Blood Advances. 2024-06-25
Epidemiology, Risk Factors, and Clinical Outcomes of AKI in Pediatric Hematopoietic Stem Cell Transplant Patients.
Omer S Ashruf, Zaid Ashruf, Zara Orozco, Matt Zinter, Rolla Abu-Arja
Kidney360. 2024-06-01

Abstracts/Posters

Long-Term Outcomes of Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV+PTLD) Following Solid Organ (SOT) or Allogeneic Hematop...
Rolla Abu-Arja, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Professional Memberships

American Society of Hematology - ASH
Member

Other Languages

Arabic